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Introduction
The coexistence of two histologically different neoplasms in one patient has become more often ob served in oncologic patients [7, 21] . However, the phe nomenon of tumourtotumour metastasis (TTTM), where one type of neoplasm gives secondary foci to another tumour is very rare. Less than 200 cases of TTTM have been reported in the literature [6, 23] . Usually the donor tumour is disseminated in such cases [6, 30] . In the case of TTTM, tumour recipients are usually slowgrowing neoplasms. Interactions of tumour cells with each other, surrounding normal cells and extracellular matrix or basement mem brane are pivotal to all stages of cancer progression [7] . The important element in cancer cell homing dur ing bloodborne dissemination is specific vascular ization and perivascular niche in host tissue [8, 27] . Metastases constitute up to 30% of all intracranial neoplasms and can be located in the brain and the meninges [8, 24, 27] . In CNS TTTM, the tumours har bouring metastases are most commonly meningio mas [20, 30] .
CNS TTTM are most often unexpected clinically and radiologically. In some instances, meningioma is detected in pathological examination of radiolo gicallydescribed metastatic lesion [12, 22] . Some of the metastatic lesions are the incidental findings within meningioma tissue and can be even the first sign of malignancy [17, 25, 31] . Some metastases cause significant oedema, necessitating rapid surgi cal resection [31] . In correct diagnosis of TTTM, it is necessary to differentiate with a rare phenomenon of collision or fusion of primary separate growth of "host" tumour and metastatic focus [2] . The role of modern neuroimaging, like functional imaging and MR spectroscopy may be helpful in preoperative diagnosis of TTTM lesions [3, 18, 23] .
Here we present two new cases of tumourtotu mour metastases with a short review of the litera ture.
Material and methods
The tumour sections were formalin fixed, paraffin embedded and HE stained for the routine diagnos tic procedures. The immunostaining was perform ed manually on representative sections with DAKO (Denmark) routine protocol and reagents. Ready touse antibodies raised against: cytokeratin (CK) AE1/AE3, 7 and 20 (CK7, CK20), epithelial membrane antigen (EMA), S100, vimentin, CD10, progesterone receptor (PR), CD44, Ecadherin and CDX2 were used. Appropriate positive and negative controls (omission of the primary antibody) were carried out for every antibody. Diaminobenzidine was the chromogen in all reactions, En Vision technology was used for vis ualization. On admission in 2009, cranial CT disclosed tu mour enlargement to 60 × 45 × 25 mm and higher con trast enhancement (Fig. 1A) . The superior part of the tumour enclosed the oval fraction which enhanced a stronger (than the rest) part of the tumour (Fig. 1B) . Segmental peritumoral oedema, especially in the re gion of the above fraction was also present (Fig. 1C) . The progression of meningioma with atypical fea tures was suggested radiologically. CT results of the lungs and abdomen were normal.
The patient underwent a total microsurgical re section of the wellvascularized bleeding meninge al mass. The postoperative course was complicat ed with a hematoma in the operative area on the third day. Hematoma was removed surgically and drained, but hemiparesis persisted. The patient was discharged to the hospice care unit and died six months later due to pneumonia.
No clinical information about patients' oncolog ic history was written on the referral card for his topathology. Grossly, the resected tumour was gray and firm, with a soft yellow area up of to 15 mm. Histolo gically, the majority of the tumour mass was made up of whorled clusters of spindle cells with few necrotic foci and mitotic index of 6/10 HPF. The separating area was composed of clear polyg onal neoplastic cells with dense delicate vascula ture (Fig. 2AB) . The immunophenotyping disclosed differences between both areas. The predominant meningioma component was positive for vimentin, EMA, S100, PR, CD44, and Ecadherin, and was CK AE1/AE3 negative. The second clear cell component showed a expression of cytokeratin, vimentin, CD10 and Ecadherin, being negative for S100, PR, and CD44 (Fig. 2CD) . The final histopathological diagno sis of atypical meningioma (II WHO) with the metas tasis of renal cell carcinoma was established.
Case 2
A 57yearold man with a twoyear history of a colorectal cancer (T3N1M0 at the diagnosis) was admitted in 2009 to the hospital due to severe head aches. His previous oncologic therapy included right hemicolectomy and adjuvant chemotherapy. On ad mission, CT revealed a contrast enhancing intrac erebral temporal lobe tumour of 25 × 32 × 30 mm surrounded with prominent oedema. He was qual ified for the resection. The neurosurgeon removed brain metastasis totally and another, radiologically not described meningeal tumorlet with a diameter of 9 × 5 mm in the parietal region. The postopera tive course was uncomplicated. The patient died one year later due to cancer dissemination to the liver and lungs.
Grossly, the resected brain tumour consisted of several fragments of greyish tissue. The meningeal tumorlet was beige and oval. Histologically, in the cerebral tumour samples, necrotizing metastatic co lonic tubular adenocarcinoma was diagnosed. The meningeal incidentaloma was a meningothelial meningioma (I WHO) bearing typical immunopheno type (S100 +, EMA +, cytokeratinsnegative, Ecad herin ++), including a 4 mm focus of a metastasis of tubular adenocarcinoma (Fig. 2EF) . The metastasis, consistent with colonic cancer, was positive for cyto keratins CKAE1/3 and CK20, also expressed CDX2 and Ecadherin.
Discussion
Tumourtotumour metastases are very rare in systemic and CNS neoplasia [2, 6, 23] . The tumoursrecipients are usually benign, as thyroid adenoma, lipoma and schwannoma, and rarely malignantbronchoalveolar lung carcinoma, thyroid carcinoma and renal cell carcinoma [23, 29] . The intracranial host tumours for metastases are most commonly meningiomas. The second most frequent type of TTTM is renal cancer metastatic to hemangioblas [17, 20] . Pamphlett and Campbell et al. found the criteria to assess a true TTTM, underlining that the metastatic focus must be enclosed by a rim of his tologically distinct host tumour tissue to exclude a collision process. Moreover, the existence of two primary tumours must be proven and histologically ascertained [6, 25] . Both cases presented here fulfil these criteria.
The pathomechanism of TTTM is still unresolved, however several ideas exist including: metabolic, vascular, hormonal, immunologic and molecular [2, 6, 26] . TTTM to meningiomas can also represent a special type of meningeal metastasis. In the case of metastases to meningioma, the rich vascular network of a meningioma provides a particular ly susceptible medium to receive a hematogenous metastasis [19, 23] . The possible role of chemokine receptor CXCR4 cooperating with CXCL12 is suggest ed [26] . Certain chemokines serve as tissuespecific attractant molecules for tumour cells, promoting cell migration to a particular site. Chemokine expression is involved in cancer metastasis by modulating neo plastic cell movement, migration and homing [7, 26] . The molecular recognition theory is exemplified by HER2positive breast cancer and its higher rate of metastases to the brain where HER2 is expressed [27] . A similar theory, used in TTTM, concerns breast cancer with Ecadherin expression and its affinity to homing within meningioma tissue with Ecadherin positivity. Interestingly, Ecadherin expression is fre quently higher in distant metastases than in prima ry tumours and often these secondary tumours are better differentiated than primary ones [10, 28] . This can be a manifestation of mesenchymalepithelial transition (MET), a process of reacquisition of epi thelial features by metastatic cells [10] .
Our Case 1 is the first reported TTTM to meningi oma with a long radiologic observation, in a patient with three different tumour types. There was proba bly a genetic background of neoplasia in this patient, but the molecular analyses were not carried out. Meningiomas show a naturally slow growth rate, especially in older patients, allowing for waitand see approach in selected patients [15, 19, 32] . Rapid exacerbation of clinical symptoms in long stand ing meningioma patients is most probably con nected with the phenomenon of progression of its grade [1, 13] . Perhaps in our patient, antiandrogenic therapy in the course of the prostatic cancer could influence meningioma biologic progression. Final ly, bloodborn RCC metastasis caused mass effect, hypervascularization, vasogenic oedema and acute neurologic symptoms. Moreover, wellvascularized TTTM caused intense postoperative bleeding. The immunophenotyping was pivotal for differentiation of RCC focus from a clear cell meningioma com ponent, especially because no clinical information about oncologic history of the patient was added.
Metastases from renal cancer to meningioma are rare and only seven cases have been described so far [5, 11, 12, 16, 17] . The patients' age ranged from 45 to 82 years. The time span between nephrectomy and different neurological symptoms due to TTTM render from several days to 7 years [12, 23] . Five cases were subtyped into: three meningothelial, one lipoma tous and one anaplastic. Interestingly, the diagnosis of RCC was based at first on the meningioma with TTTM investigation in three cases [5, 11, 16] .
The other types of cancer metastasis to meningi oma include lung, breast, prostate and single cases of other malignancies [4, 22, 30] . The second of our TTTM cases -the incidentaloma is one of extremely rare cases, where TTTM accompanied synchronous cancer metastases to the brain. This is also one of few examples of colon cancer deposits within men ingioma. Our TTTM was small, localized outside the vascularization region of big cerebral adenocarci noma metastasis. In this patient, CNS metastases preceded generalized cancer systemic dissemina tion.
It is difficult to diagnose TTTM based on imaging and intraoperative gross clinical picture. In our Case 1, the oval stronger enhancing component in the upper part of the meningioma was a metastatic focus, but CT exam was interpreted as focal malignant trans formation. Radiologically, there are some features of atypical meningioma on CT scanning: heterogene ous appearance, homogeneous dense enhancement after contrast injection, bone destruction and per itumoral oedema [9, 14, 18] . RCC and its metastases are hypervascular lesions and a high enhancement after contrast medium administration is typically noted. However, the same enhancement pattern is observed in meningioma with necrotic changes and cystic degeneration [3, 18] . It is extremely difficult to distinguish two different tumours in one pathologi cal mass without histological examination, especial ly in the case of a similar type of vasculature [14] . In Case 2, a radiologic report focused on a cerebral metastasis and signs of peritumoral oedema, whilst small meningeal tumour was not described at all. MR spectroscopy can be a helpful diagnostic tool in differential diagnosis of dural metastases versus meningioma and even TTTM. Moreover, diffusion and perfusion MRI techniques will enable diagnos tic efficacy. However, despite modern neuroimaging, pathological examination is crucial for correct diag nosis [3, 18, 30] .
Cancer metastasis to meningioma can be the first manifestation of the metastatic stage of dis ease or can arise during neoplastic hematogenous dissemination. Often there are limited clinical conse quences of TTTM, but high vascularization of these tumours can cause peritumoral oedema and the postoperative haemorrhage. Metastasis to meningi oma should be included into histopathological diag nosis scope of meningeal masses in patients with systemic malignancies. Our cases prove the impor tance of the careful gross inspection and sampling of tumours and necessity of immunohistochemistry in differential diagnosis between multiple meningio ma subtypes and possible metastatic focus.
